Aktis Oncology, Inc. ROE

The ROE as of November 2026 (TTM) for Aktis Oncology, Inc. (AKTS) is -41.07%

According to Aktis Oncology, Inc.’s latest financial reports and current stock price. The company's current ROE is -41.07%. This represents a change of -1317.70% compared to the average of 3.37% of the last 4 quarters.

Aktis Oncology, Inc. (AKTS) Historical ROE (quarterly & annually)

How has AKTS ROE performed in the past?

The mean historical ROE of Aktis Oncology, Inc. over the last ten years is 62.20%. The current -41.07% ROE has changed -166.03% with respect to the historical average. Over the past ten years (40 quarters), AKTS's ROE was at its highest in in the December 2024 quarter at 13.73%. The ROE was at its lowest in in the June 2026 quarter at -4.98%.

Aktis Oncology, Inc. (AKTS) ROE by Quarter and Year

Discovering the peaks and valleys of Aktis Oncology, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Aktis Oncology, Inc. (AKTS) Average ROE

How has AKTS ROE performed in the past?

The current ROE of Aktis Oncology, Inc. (AKTS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Aktis Oncology, Inc. (AKTS) ROE vs. Peers

How is AKTS’s ROE compared to its peers?

Aktis Oncology, Inc.’s ROE is greater than Bicycle Therapeutics plc (-26.02%), greater than Akari Therapeutics, Plc (-147.45%), greater than Immunome, Inc. (-50.56%), greater than MacroGenics, Inc. (-31.27%), greater than Immunocore Holdings plc (-2.35%), greater than Aura Biosciences, Inc. (-73.18%),

Build a custom stock screener for Aktis Oncology, Inc. (AKTS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Aktis Oncology, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Aktis Oncology, Inc. (AKTS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Aktis Oncology, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.